Insider Trading & Ownership - Borgeson Blake

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Borgeson Blake
Goto Prev, 0, 1
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2023-06-27
Sale		 2023-06-29
5:57 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $7.3876 $65,639 7,528,989
(Direct)		 View
2023-06-13
Sale		 2023-06-15
7:30 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 15,485 $9.9778 $154,506 7,525,262
(Direct)		 View
2023-05-30
Sale		 2023-06-01
5:41 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $8.7939 $78,134 7,540,747
(Direct)		 View
2023-05-16
Sale		 2023-05-17
6:22 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $5.0918 $45,241 7,549,632
(Direct)		 View
2023-04-18
Sale		 2023-04-20
5:37 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $5.9347 $52,730 7,558,517
(Direct)		 View
2023-04-04
Sale		 2023-04-06
5:38 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $6.5269 $57,992 7,567,402
(Direct)		 View
2023-03-21
Sale		 2023-03-23
5:07 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $7.3994 $65,744 7,576,287
(Direct)		 View
2023-03-07
Sale		 2023-03-09
5:36 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $8.3274 $73,989 7,585,172
(Direct)		 View
2023-02-21
Sale		 2023-02-23
5:48 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $7.733 $68,708 7,594,057
(Direct)		 View
2023-02-07
Sale		 2023-02-09
4:53 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $8.8084 $78,263 7,602,942
(Direct)		 View
2023-01-24
Sale		 2023-01-26
6:04 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $8.7077 $77,368 7,611,827
(Direct)		 View
2023-01-10
Sale		 2023-01-12
5:46 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $7.6852 $68,283 7,620,712
(Direct)		 View
2022-12-27
Sale		 2022-12-29
5:39 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $7.2451 $64,373 7,628,272
(Direct)		 View
2022-12-13
Sale		 2022-12-15
5:26 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $8.9587 $79,598 7,637,157
(Direct)		 View
2022-11-29
Sale		 2022-12-01
5:14 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 8,885 $8.7547 $77,786 7,646,042
(Direct)		 View
2022-11-16
Sale		 2022-11-18
5:47 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 17,770 $11.12 $197,610 7,654,927
(Direct)		 View
2022-01-04
Sale		 2022-01-05
8:39 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 9,625 $18.03 $173,528 7,651,146
(Direct)		 View
2021-12-21
Sale		 2021-12-23
5:05 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 9,625 $18.75 $180,478 7,660,216
(Direct)		 View
2021-12-07
Sale		 2021-12-09
9:23 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 9,625 $20.32 $195,533 7,669,841
(Direct)		 View
2021-11-18
Sale		 2021-11-22
8:20 pm		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 9,625 $18.91 $182,005 7,679,466
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2023-06-16
Option Award		 2023-06-21
5:24 pm		 2024-06-16
2033-06-16		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 37,836 $0 7,611,888
(Direct)		 View
2023-01-03
Option Award		 2023-01-05
6:28 pm		 N/A
N/A		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 1,325 $0 7,629,597
(Direct)		 View
2022-10-03
Option Award		 2022-10-05
9:10 pm		 N/A
N/A		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 920 $0 7,672,697
(Direct)		 View
2022-07-01
Option Award		 2022-07-06
5:47 pm		 N/A
N/A		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 1,186 $0 7,671,777
(Direct)		 View
2022-06-14
Option Award		 2022-06-16
8:19 pm		 2023-06-14
2032-06-14		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 54,435 $0 7,719,381
(Direct)		 View
2022-04-01
Option Award		 2022-04-05
7:25 pm		 N/A
N/A		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 1,300 $0 7,652,446
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
8:39 pm		 N/A
N/A		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 555 $0 7,651,146
(Direct)		 View
2021-10-01
Option Award		 2021-10-05
8:28 pm		 N/A
N/A		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 457 $0 7,689,091
(Direct)		 View
2021-07-01
Option Award		 2021-07-06
5:01 pm		 N/A
N/A		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 278 $0 7,688,634
(Direct)		 View
2021-04-20
Conversion		 2021-04-22
7:50 pm		 N/A
N/A		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 9,559,460 $0 7,700,856
(Direct)		 View
2021-04-15
Option Award		 2021-04-19
7:21 pm		 N/A
2031-04-14		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 18,750 $0 7,700,856
(Direct)		 View

Ownership		 2021-04-15
08:53 am		 N/A
N/A		 RECURSION PHARMACEUTICALS INC. RXRX Borgeson Blake
Director		 0 $0 7,682,106
(Direct)		 View
Goto Prev, 0, 1